Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Immune Modulation Therapy for Pompe Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Quantitating the Impact of Plerixafor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Belimumab Impacting Transplant Eligibility
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
- Status
- TERMINATED
- Phase
- PHASE3
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
- Status
- COMPLETED
- Phase
- PHASE2
Optimising Renal Outcome in Myeloma Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2